Impact of radiation dose and standardized uptake value of (18)FDG PET on nodal control in locally advanced cervical cancer

References

• Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol 2009;36:155–69.
   PubMed Web of Science ®Google Scholar
• Ahmad R, Bondar L, Voet P, Mens JW, Quint S, Dhawtal G, et al. A margin-of-the-day online adaptive intensity- modulated radiotherapy strategy for cervical cancer provides superior treatment accuracy compared to clinically recommended margins: A dosimetric evaluation. Acta Oncol 2013; 52:1430–6.
   PubMed Web of Science ®Google Scholar
• Fokdal L, Tanderup K, Hokland SB, Rohl L, Pedersen EM, Nielsen SK, et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Radiother Oncol 2013;107:63–8.
   PubMed Web of Science ®Google Scholar
• Schmid MP, Fidarova E, Potter R, Petric P, Bauer V, Woehs V, et al. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy. Acta Oncol 2013;52: 1384–90.
   PubMed Web of Science ®Google Scholar
• Palmqvist T, Dybdahl Wanderas A, Langeland Marthinsen AB, Sundset M, Langdal I, Danielsen S, et al. Dosimetric evaluation of manually and inversely optimized treatment planning for high dose rate brachytherapy of cervical cancer. Acta Oncol 2014;53:1012–8.
   PubMed Web of Science ®Google Scholar
• Hegazy N, Potter R, Kirisits C, Berger D, Federico M, Sturdza A, et al. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy: Impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination. Acta Oncol 2013;52:1345–52.
   PubMed Web of Science ®Google Scholar
• Petric P, Hudej R, Rogelj P, Blas M, Tanderup K, Fidarova E, et al. Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer: A multi-institutional study. Radiother Oncol 2013;107:6–12.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Fokdal LU, Nielsen SK, Juul-Christensen J, Tanderup K. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013;52:1510–9.
   PubMed Web of Science ®Google Scholar
• Nomden CN, de Leeuw AA, Roesink JM, Tersteeg RJ, Moerland MA, Witteveen PO, et al. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: A single institution experience. Radiother Oncol 2013;107:69–74.
   PubMed Web of Science ®Google Scholar
• Potter R, Georg P, Dimopoulos JC, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011;100:116–23.
   PubMed Web of Science ®Google Scholar
• Cosin JA, Fowler JM, Chen MD, Paley PJ, Carson LF, Twiggs LB. Pretreatment surgical staging of patients with cervical carcinoma: The case for lymph node debulking. Cancer 1998;82:2241–8.
   PubMed Web of Science ®Google Scholar
• Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, et al. Lymph node staging by positron emission tomography in cervical cancer: Relationship to prognosis. J Clin Oncol 2010;28:2108–13.
   PubMed Web of Science ®Google Scholar
• Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer. Cancer 2010;116:1469–75.
   PubMed Web of Science ®Google Scholar
• Gaffney DK, Erickson-Wittmann BA, Jhingran A, Mayr NA, Puthawala AA, Moore D, et al. ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on radiation oncology-gynecology. Int J Radiat Oncol Biol Phys 2011;81:609–14.
   PubMed Web of Science ®Google Scholar
• Cihoric N, Tapia C, Kruger K, Aebersold DM, Klaeser B, Lossl K. IMRT with (1)(8)FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer. Radiat Oncol 2014;9:83–717X–9–83.
   PubMed Web of Science ®Google Scholar
• Vargo JA, Kim H, Choi S, Sukumvanich P, Olawaiye AB, Kelley JL et al. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: Analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. Int J Radiat Oncol Biol Phys 2014;90:1091–8.
   PubMed Web of Science ®Google Scholar
• Rash DL, Lee YC, Kashefi A, Durbin-Johnson B, Mathai M, Valicenti R, et al. Clinical response of pelvic and para-aortic lymphadenopathy to a radiation boost in the definitive management of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2013;87:317–22.
   PubMed Web of Science ®Google Scholar
• Mohamed SM, Aagaard T, Fokdal LU, Pedersen EM, Lindegaard JC, Tanderup K. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer. Brachytherapy 2015;14:56–61.
   PubMed Web of Science ®Google Scholar
• van den Bos W, Beriwal S, Velema L, de Leeuw AA, Nomden CN, Jurgenliemk-Schulz IM. Image guided adaptive brachytherapy for cervical cancer: Dose contribution to involved pelvic nodes in two cancer centers. J Contemp Brachytherapy 2014;6:21–7.
   PubMed Web of Science ®Google Scholar
• Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ. Patterns of regional recurrence after definitive radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2010;76:1396–403.
   PubMed Web of Science ®Google Scholar
• Ariga T, Toita T, Kasuya G, Nagai Y, Inamine M, Kudaka W, et al. External beam boost irradiation for clinically positive pelvic nodes in patients with uterine cervical cancer. J Radiat Res 2013;54:690–6.
   PubMed Web of Science ®Google Scholar
• Gouy S, Morice P, Narducci F, Uzan C, Martinez A, Rey A, et al. Prospective multicenter study evaluating the survival of patients with locally advanced cervical cancer undergoing laparoscopic para-aortic lymphadenectomy before chemoradiotherapy in the era of positron emission tomography imaging. J Clin Oncol 2013;31:3026–33.
   PubMed Web of Science ®Google Scholar
• Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL et al. Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: A prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer 2011;117:1928–34.
   PubMed Web of Science ®Google Scholar
• Bol GH, Kotte AN, van der Heide UA, Lagendijk JJ. Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed 2009;96:133–40.
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Singh AK, Siegel BA, Dehdashti F, Rader J, Zoberi I. Lymph node control in cervical cancer. Int J Radiat Oncol Biol Phys 2004;59:706–12.
   PubMed Web of Science ®Google Scholar
• Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802–12.
   PubMed Web of Science ®Google Scholar
• Onal C, Guler OC, Reyhan M, Yapar AF. Prognostic value of (18)F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy. Gynecol Oncol 2015;137:40–6.
   PubMed Web of Science ®Google Scholar
• Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 2015;42:328–54.
   PubMed Web of Science ®Google Scholar
• Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, et al. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol 2014;21:3–8.
   PubMed Web of Science ®Google Scholar